Pataday (olopatadine) is filed as Ophthalmic Antihistamine. The sections below restate public label fields stored for this profile.
Uses temporarily relieves itchy and red eyes due to pollen, ragweed, grass, animal hair and dander
Warnings For external use only
Drug Facts Active Ingredients Purpose Olopatadine (0.1%) (equivalent to olopatadine hydrochloride 0.111%) Antihistamine and Redness Reliever
Directions adults and children 2 years of age and older: put 1 drop in the affected eye(s) twice daily, every 6 to 8 hours, no more than twice per day if using other ophthalmic products while using this product, wait at least 5 minutes between each product replace cap after each use children under 2 years of age: consult a doctor
According to its FDA label, Pataday (olopatadine) is approved for: Uses temporarily relieves itchy and red eyes due to pollen, ragweed, grass, animal hair and dander For medical advice, please talk to your prescriber or pharmacist.
Pataday (olopatadine) belongs to the Ophthalmic Antihistamine class of medications.
The FDA label lists Pataday (olopatadine) as: ophthalmic route. Available strengths and packaging vary by manufacturer.
Yes. A generic version of Pataday (olopatadine) is available in the U.S. Ask your pharmacist about substitution.
Our ingest of the FDA label for Pataday (olopatadine) does not include a Boxed Warning at this time. See the full label on DailyMed for the current, authoritative version.
Public CMS NADAC pricing for Pataday (olopatadine) is in the range Retail prices vary widely by pharmacy, insurance, and location. Check with your pharmacy or use tools like GoodRx for current pricing.. Retail price varies by pharmacy, insurance, and manufacturer coupons.
The FDA Enforcement Report does not show an active/ongoing recall for Pataday (olopatadine) in our latest ingest. Recall data can change daily — verify at FDA.gov.
The FDA record lists the approval date for Pataday (olopatadine) as 2017-07-26.
The FDA label lists WAL-MART STORES, INC., as a labeler/manufacturer of Pataday (olopatadine). Multiple firms may market generics of the same molecule.
Loading full data from Know Your Drugs Institute…